- ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.
Strong drug sales allow the German group to increase its full-year earnings forecast, while wilting crop science revenue pose more questions about the wisdom of buying Monsanto.
U.K. lender Lloyds falls after a third-quarter profit miss, while luxury goods maker Kering surges.
Index funds are great, Jim Cramer says, but he encourages investors to do some smart stock picking.